Yahoo Finance • 6 days ago

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

Publication details large multicenter clinical trial demonstrating significant reductions in IBS symptoms through inFoods IBS guided dietary therapy IRVINE, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a glo... Full story

Yahoo Finance • 25 days ago

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

Rising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service ExpansionComprehensive CDMO services now featured on Biomerica’s updated website IRVINE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc.... Full story

Yahoo Finance • 2 months ago

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.

- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation’s Most Trusted Health Care Distributors - Relationship Marks a Key Milestone in Biomerica’s Commercialization Strategy IRVINE, Calif., Oct. 16, 2025... Full story

Yahoo Finance • 2 months ago

Biomerica Reports First Quarter Fiscal 2026 Financial Results

Reported Improved Gross Margin from Contribution from Higher-Margin Product Mix Operating Expenses Continued to Decline Compared to the First Quarter of the Prior Fiscal Year, Reflecting the Company’s Ongoing Focus on Cost Reduction and Op... Full story

Yahoo Finance • 2 months ago

Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growth Extensive track record in commercializing advanced laboratory testing and insurer strategies IRVINE, Calif., Oct. 08, 2025 (GLOB... Full story

Yahoo Finance • 3 months ago

Biomerica Launches AI-Backed inFoods® IBS Trigger Food Navigator to Support Personalized IBS Therapy and Improve Patient Outcomes

New AI-enabled digital tool empowers patients to confidently manage IBS symptoms and avoid the trigger foods identified by inFoods® IBS testingIBS affects an estimated 40 million adults in the U.S. and hundreds of millions worldwide IRVIN... Full story

Yahoo Finance • 3 months ago

Curious about the stocks that are showing activity after the closing bell on Wednesday?

As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. [postmarket] GAINERS TICKER CHANGE COMMENT... Full story

Yahoo Finance • 3 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Test for Home Use

10-minute home test detects early kidney damage in diabetic and hypertensive patientsHypertension affects roughly one-third of adults in the UAEDiabetes impacts approximately one in four UAE nationals IRVINE, Calif., Sept. 03, 2025 (GLO... Full story

Yahoo Finance • 3 months ago

Biomerica Reports Fiscal 2025 Year End Results

$1.3 Million in Operating Expense Reductions Achieved– Operating Loss Improves 19% Year-Over-Year Resilient Portfolio Performance with International Sales Despite Global Economic Uncertainties Cash Used in Operating Activities Reduced to $... Full story

Yahoo Finance • 4 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Home Use

10-minute home test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerH. pylori linked to approximately 80% of gastric cancer cases; classified as a Class 1 carcinogen by the World Hea... Full story

Yahoo Finance • 5 months ago

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

PLA Code issuance by the American Medical Association CPT editorial panel marks a meaningful step toward attaining health insurance reimbursement and expanded patient access for inFoods® IBS inFoods® IBS provides personalized identificatio... Full story

Yahoo Finance • 5 months ago

Biomerica names Scott Madel as chief commercial officer

IRVINE, Calif. - Biomerica Inc. (NASDAQ:BMRA), a microcap diagnostic company with a market capitalization of approximately $8 million, has appointed Scott Madel as Chief Commercial Officer, the company announced Thursday in a press release... Full story

Yahoo Finance • 5 months ago

Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica’s Team as Chief Commercial Officer

Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansion Led successful organizational turnarounds and growth strategies at both Boston Heart Diagnostics and Genova Diagnostics Extensiv... Full story

Yahoo Finance • 6 months ago

Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair

Mr. Chin brings over 20 years of financial experience across public and private healthcare organizationsMr. Chin currently serves as CFO of Akido Labs where he successfully helped raise $60 million in a recent financingMr. Chin’s appointme... Full story

Yahoo Finance • 6 months ago

Biomerica’s inFoods® IBS Clinical Study Results Published in June Issue of Gastroenterology

Landmark Peer-Reviewed Study Demonstrates Effectiveness of Personalized Dietary Therapy for IBS Patients Using inFoods® IBS Test.Gastroenterology, the premier journal in gastrointestinal science, features data supporting inFoods IBS as an... Full story

Yahoo Finance • 6 months ago

Biomerica Reports Real-World Data Showing 49% Reduction in IBS Symptoms with inFoods® IBS using a First of Its Kind Real-Time IBS Patient Feedback System

Real-World Impact: Initial data from over 360 patients shows inFoods® IBS delivered an average 48.5% reduction in gastrointestinal pain and a 49.8% reduction in bloating over an 8-week period First-of-Its-Kind inFoods® IBS Feedback Platfor... Full story

Yahoo Finance • 7 months ago

PLA Code Application Filed for inFoods IBS Test — A Key Step Toward Reimbursement

- Application represents milestone toward broadening patient access to inFoods IBS - inFoods® IBS pinpoints patient-specific foods that can trigger IBS symptoms like bloating, abdominal pain, diarrhea, and constipation IRVINE, Calif. , M... Full story

Yahoo Finance • 7 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Ulcer Test for Detection of H. pylori Infection

10-minute test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerApproximately 80% of gastric cancer cases are linked to H. pylori infection; WHO classifies H. pylori as a Class 1 carc... Full story

Yahoo Finance • 8 months ago

United Arab Emirates Ministry of Health and Prevention Approves Biomerica’s Fortel® Kidney Disease Test for Early Detection of Kidney Damage

Regulatory milestone enables commercial expansion into high-need international market10-minute test detects early signs of kidney damage using a simple urine sample Addresses global public health burden of Chronic Kidney Disease (CKD), wit... Full story

Yahoo Finance • 8 months ago

Biomerica Announces Reverse Stock Split

IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) (“Biomerica”), a global provider of advanced medical products, today announced that it will implement a 1-for-8 reverse stock split of the issued and outst... Full story